Neurology Research International / 2012 / Article / Fig 2

Clinical Study

A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression

Figure 2

Average pNFH levels in patients who lost <0.5 ALSFRS-R points per month compared to patients who lost >0.5 ALFRS-R points per month. (*Significant difference between the slow and fast progressors, by Mann-Whitney t-test). Error bars denote standard deviation.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.